These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 38227115

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data.
    Xiao S, Wang J, Xiao N.
    Int J Biol Markers; 2016 Jul 30; 31(3):e276-85. PubMed ID: 26954073
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.
    Shi HB, Yu JX, Yu JX, Feng Z, Zhang C, Li GY, Zhao RN, Yang XB.
    World J Surg Oncol; 2017 Aug 03; 15(1):147. PubMed ID: 28774300
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Zhan Y, Du L, Wang L, Jiang X, Zhang S, Li J, Yan K, Duan W, Zhao Y, Wang L, Wang Y, Wang C.
    Mol Cancer; 2018 Sep 29; 17(1):142. PubMed ID: 30268126
    [Abstract] [Full Text] [Related]

  • 8. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
    Wang J, Yang K, Yuan W, Gao Z.
    Med Sci Monit; 2018 Dec 21; 24():9307-9316. PubMed ID: 30576305
    [Abstract] [Full Text] [Related]

  • 9. Exosomal noncoding RNAs in prostate cancer.
    Movahedpour A, Khatami SH, Karami N, Vakili O, Naeli P, Jamali Z, Shabaninejad Z, Tazik K, Behrouj H, Ghasemi H.
    Clin Chim Acta; 2022 Dec 01; 537():127-132. PubMed ID: 36330945
    [Abstract] [Full Text] [Related]

  • 10. Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma.
    Chen C, Shang A, Sun Z, Gao Y, Huang J, Ping Y, Chang W, Gu C, Sun J, Ji P, Yuan Y, Lu R, Li D.
    J Immunol Res; 2022 Dec 01; 2022():9038808. PubMed ID: 35127956
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis.
    Ye Q, Wang J, Xu D, Liu Y, Zhang D, Ye J, Li H.
    Expert Rev Anticancer Ther; 2022 Dec 01; 22(12):1357-1369. PubMed ID: 36374119
    [Abstract] [Full Text] [Related]

  • 12. Circulating noncoding RNAs as early predictive biomarkers in preeclampsia: a diagnostic meta-analysis.
    Su S, Yang F, Zhong L, Pang L.
    Reprod Biol Endocrinol; 2021 Dec 01; 19(1):177. PubMed ID: 34852820
    [Abstract] [Full Text] [Related]

  • 13. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
    Zhang L, Hu C, Huang Z, Li Z, Zhang Q, He Y.
    PLoS One; 2021 Dec 01; 16(4):e0250717. PubMed ID: 33901236
    [Abstract] [Full Text] [Related]

  • 14. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
    Zheng R, Du M, Wang X, Xu W, Liang J, Wang W, Lv Q, Qin C, Chu H, Wang M, Yuan L, Qian J, Zhang Z.
    Mol Cancer; 2018 Oct 03; 17(1):143. PubMed ID: 30285771
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circulating long noncoding RNAs as potential biomarkers for stomach cancer: a systematic review and meta-analysis.
    Cao F, Hu Y, Chen Z, Han W, Lu W, Xu J, Ding H, Shen X.
    World J Surg Oncol; 2021 Mar 26; 19(1):89. PubMed ID: 33771184
    [Abstract] [Full Text] [Related]

  • 17. Plasma-derived exosomal long noncoding RNAs of pancreatic cancer patients as novel blood-based biomarkers of disease.
    He X, Chen L, Di Y, Li W, Zhang X, Bai Z, Wang Z, Liu S, Corpe C, Wang J.
    BMC Cancer; 2024 Aug 06; 24(1):961. PubMed ID: 39107726
    [Abstract] [Full Text] [Related]

  • 18. Exosome-Derived Long Non-Coding RNAs as Non-Invasive Biomarkers of Bladder Cancer.
    Su Q, Wu H, Zhang Z, Lu C, Zhang L, Zuo L.
    Front Oncol; 2021 Aug 06; 11():719863. PubMed ID: 34490118
    [Abstract] [Full Text] [Related]

  • 19. The value of urinary exosomal lncRNA SNHG16 as a diagnostic biomarker for bladder cancer.
    Liu C, Xu P, Shao S, Wang F, Zheng Z, Li S, Liu W, Li G.
    Mol Biol Rep; 2023 Oct 06; 50(10):8297-8304. PubMed ID: 37592177
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.
    Zhang S, Du L, Wang L, Jiang X, Zhan Y, Li J, Yan K, Duan W, Zhao Y, Wang L, Wang Y, Shi Y, Wang C.
    J Cell Mol Med; 2019 Feb 06; 23(2):1396-1405. PubMed ID: 30467945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.